Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...

A recent survey reveals the foods that people are less likely to eat once they start taking GLP-1 medications like Ozempic.

In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...

Administration officials reversed a decision made during the Biden presidency that would have given millions of people access ...

The Centers for Medicare and Medicaid Services said it would not cover the medications under Medicare’s Part D coverage.

Donald Trump’s team gutted the Biden administration’s plan as part of a sprawling 438-page regulation update that tweaks how beneficiaries get drug coverage ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Trump administration rejects a Biden plan to expand Medicare coverage of weight-loss drugs such as Zepbound and Wegovy.

along with diet and exercise. With off-label use, doctors prescribe a drug for a use that the FDA has not approved. Wegovy is FDA approved to help weight loss and long-term weight management in ...

CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they ...